as 09-06-2024 4:00pm EST
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
Founded: | 1984 | Country: | Australia |
Employees: | N/A | City: | N/A |
Market Cap: | 201.5M | IPO Year: | 2020 |
Target Price: | $14.00 | AVG Volume (30 days): | 11.2K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.35 | EPS Growth: | N/A |
52 Week Low/High: | $1.60 - $4.40 | Next Earning Date: | 08-30-2024 |
Revenue: | $261,859 | Revenue Growth: | -32.03% |
Revenue Growth (this year): | -44.93% | Revenue Growth (next year): | 55563.16% |
OPT Breaking Stock News: Dive into OPT Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
GlobeNewswire
3 days ago
Insider Monkey
4 days ago
GlobeNewswire
5 days ago
Simply Wall St.
6 days ago
Simply Wall St.
7 days ago
GlobeNewswire
9 days ago
GlobeNewswire
a month ago
The information presented on this page, "OPT Opthea Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.